|
H3: duct analysis #(b)(4) :equipment used: video inspection system (m-85519), ruler (m-83360), camera (panasonic lumix dmc-zs5, in-house coil (model: apb-4-12-3d-ss lot: a158525) drawing(s) referenced: dwgs105-5092-150 rev.Bj as found condition: two echelon-14 micro catheters and one axium device within a shipping box; within a sealed plastic biohazard pouch; within two opened outer cartons and within two different opened inner pouches.The axium device was returned outside its returned introducer sheath.Visual inspection/damage location details: (first echelon-14) no damages or irregularities were found with the echelon-14 hub.No bends or kinks were found with the echelon-14 catheter body.The echelon-14 distal tip and distal marker band was found damaged (ovalized) (figure g).The distal micro catheter appears to be steam shaped (figure f).(second echelon-14) no damages or irregularities were found with the echelon-14 hub.No bends or kinks were found with the echelon-14 catheter body.The echelon-14 distal tip and distal marker band was found damaged (ovalized) (figure o).The distal micro catheter appears to be steam shaped (figure n).(axium) no damages or irregularities were found with the introducer sheath.No damages or irregularities were found with the axium pusher.The axium implant coil was found severely stretched (figure k) with the polypropylene filament broken (figure l).Testing/analysis: (axium) the axium device could not be used for resistance testing due to the damaged condition.(first echelon-14) the echelon-14 total length was measured to be ~155.1cm and the useable length was measured to be ~147.2cm which is within specification (specification: total (ref) = 155cm; usable = 147.0 cm ± 1.5cm).The echelon-14 micro catheter was flushed; water exited from the distal tip.An in-house coil (model: apb-4-12-3d-ss lot: a158525) was inserted into the hub, through the micro catheter body and out the distal end with no resistance encountered (figure h).The inner diameter of the hub was measured to be 0.0165¿, which is within specification (specification: 0.0165¿ minimum).The mandrel used to measure the hub felt slight resistance at the fuse joint between grilamid and proximal catheter (figure j).No gap was found between the hub and grilamid (figure i).This catheter likely is pli-10 due to the step found.(second echelon-14) the echelon-14 total length was measured to be ~154.8cm and the useable length was measured to be ~147.0cm, which is within specification (specification: total (ref) = 155cm; usable = 147.0 cm ± 1.5cm).The echelon-14 micro catheter was flushed; water exited from the distal tip.An in-house coil (model: apb-4-12-3d-ss lot: a158525) was inserted into the hub, through the micro catheter body and out the distal end with no resistance encountered (figure p).The inner diameter of the hub was measured to be 0.0165¿, which is within specification (specification: 0.0165¿ minimum).No gap was found between the grilamid and hub (figure q).No step was found between the grilamid and proximal catheter (figure r).Conclusion: based on the device analysis and reported information, the customer¿s report of ¿resistance at hub¿ and ¿coil resistance/stuck at cath.Hub¿ were confirmed.The investigation determined that the cause of the resistance was likely due to a ¿step¿ between the grilamid and the proximal catheter, although the step did not contribute towards resistance during in-house resistance testing.The step in the hub is formed when grilamid (nylon tubing) is not fully fused on to the catheter during hub assembly.The potential for forming a ¿hub step¿ is most likely attributed to manufacturing failure.There was an indication that the event is related to a potential manufacturing issue; therefore, a device history record review will be performed.The customer report of ¿coil stretch¿ was confirmed.It is likely that the coil became stretched due to advancing/retracting the device against the reported resistance.The distal catheter tips and distal marker bands were found ovalized for both echelon-14s, however, these damages did not contribute towards resistance during analysis.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|